| Literature DB >> 24376832 |
Xiaoling Tang1, Huixing Feng1, Jianhua Zhang1, Wei Ning Chen1.
Abstract
The yeast Saccharomyces cerevisiae was metabolically modified for enhanced biofuel precursor production by knocking out genes encoding mitochondrial isocitrate dehydrogenase and over-expression of a heterologous ATP-citrate lyase. A comparative iTRAQ-coupled 2D LC-MS/MS analysis was performed to obtain a global overview of ubiquitous protein expression changes in S. cerevisiae engineered strains. More than 300 proteins were identified. Among these proteins, 37 were found differentially expressed in engineered strains and they were classified into specific categories based on their enzyme functions. Most of the proteins involved in glycolytic and pyruvate branch-point pathways were found to be up-regulated and the proteins involved in respiration and glyoxylate pathway were however found to be down-regulated in engineered strains. Moreover, the metabolic modification of S. cerevisiae cells resulted in a number of up-regulated proteins involved in stress response and differentially expressed proteins involved in amino acid metabolism and protein biosynthesis pathways. These LC-MS/MS based proteomics analysis results not only offered extensive information in identifying potential protein-protein interactions, signal pathways and ubiquitous cellular changes elicited by the engineered pathways, but also provided a meaningful biological information platform serving further modification of yeast cells for enhanced biofuel production.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24376832 PMCID: PMC3871657 DOI: 10.1371/journal.pone.0084661
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Relative changes in protein expression between S. cerevisiae wild type and engineered strains.
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
| PGI1 | Glucose 6-phosphate isomerase | 19 | 1.44±0.014 | 1.46±0.205 |
| TPI1 | Triosephosphate isomerase | 15 | 1.80±0.021 | 2.50±0.460 |
| TDH3 | Glyceraldehydes-3-phosphate dehydrogenase 3 | 24 | 1.43±0.036 | 1.60±0.071 |
| GPM1 | Phosphoglycerate mutase | 19 | 1.45±0.010 | 1.48±0.216 |
| PYK1 | Pyruvate kinase | 35 | 1.34±0.022 | 1.45±0.004 |
|
| ||||
| PDC1 | Pyruvate decarboxylase isozyme 1 | 26 | 1.35±0.002 | 1.65±0.057 |
| ADH1 | Alcohol dehydrogenase 1 | 15 | 1.57±0.345 | 1.60±0.004 |
| PYC2 | Pyruvate carboxylase 2 | 2 | 1.21±0.107 | 1.30±0.176 |
|
| ||||
| PDA1 | Pyruvate dehydrogenase E1 component subunit | 3 | 1.39±0.300 | 1.54±0.106 |
| ACO1 | Aconitate hydratase | 19 | 1.75±0.132 | 2.48±0.113 |
| SDH1 | Succinate dehydrogenase | 2 | -- | 0.55±0.190 |
|
| ||||
| ICL1 | Isocitrate lyase | 6 | 0.68±0.019 | 0.77±0.028 |
| MLS1 | Malate synthase | 6 | 0.62±0.105 | 0.53±0.007 |
|
| ||||
| UGP1 | UTP—glucose-1-phosphate uridylyltransferase | 2 | 1.77±0.058 | 1.84±0.064 |
|
| ||||
| MCR1 | NADH-cytochrome b5 reductase 2 | 4 | 0.55±0.026 | 0.58±0.035 |
| GPD1 | Glycerol-3-phosphate dehydrogenase 1 | 3 | 0.43±0.019 | 0.27±0.011 |
| AAC2 | ADP, ATP carrier protein 2 | 2 | 0.79±0.113 | 0.73±0.060 |
|
| ||||
| TRX2 | Thioredoxin-2 | 6 | 1.57±0.024 | 1.83±0.148 |
| GRX2 | Glutaredoxin 2, mitochondrial | 5 | -- | 1.46±0.032 |
| AHP1 | Peroxiredoxin type 2 | 12 | 1.04±0.018 | 1.76±0.265 |
|
| ||||
| ASN1 | Asparagine synthetase | 5 | 1.99±0.488 | 2.86±0.672 |
| HOM2 | Asparatate-semialdehyde dehydrogenase | 3 | 1.28±0.045 | 1.33±0.138 |
| AAT2 | Aspartate aminotransferase | 2 | -- | 1.55±0.074 |
| HOM6 | Homoserine dehydrogenase | 10 | 1.31±0.010 | 1.26±0.014 |
| SHM2 | Serine hydroxymethyltransferase | 9 | 0.51±0.150 | 0.57±0.042 |
| ARG1 | Argininosuccinate synthase | 3 | -- | 1.84±0.251 |
|
| ||||
| YEF3 | Elongation factor 3A | 6 | 1.21±0.004 | 1.71±0.042 |
| RPL3 | 60s ribosomal protein L3 | 4 | 1.35±0.128 | 1.49±0.057 |
| RPL8B | 60s ribosomal proteion L8-B | 3 | 1.6±0.007 | 1.84±0.360 |
| RPS0A | 40s ribosomal protein S0-A | 3 | 1.12±0.031 | 1.52±0.219 |
| RPS5 | 40s ribosomalprotein S5 | 2 | 1.42±0.111 | 1.55±0.060 |
|
| ||||
| SSA1 | Heat shock protein SSA1 | 32 | 1.02±0.001 | 1.55±0.085 |
| HSP26 | Heat shock protein 26 | 12 | 0.99±0.005 | 1.60±0.039 |
|
| ||||
| MPG1 | Mannose-1-phosphate guanyltransferase | 3 | 1.43±0.104 | 1.54±0.173 |
| GPP1 | (DL)-glycerol-3-phosphatase 1 | 6 | 0.99±0.011 | 1.36±0.095 |
| ADE13 | Adenylosuccinate lyase | 3 | 1.31±0.034 | 1.76±0.085 |
| INO1 | Inositol-3-phosphate synthase | 5 | 0.77±0.015 | 0.75±0.028 |
The “Average of A/C” refers to the average ratio of protein expression level in ∆idh1/2-pvtu strain over that in wt-pvtu strain and “Average of B/C”refers to the average ratio of protein expression level in ∆idh1/2-acl strain over that in wt-pvtu strain. Herein, each protein expression level in wt-pvtu was taken 100% and the deviation was calculated from three independently LC-MS/MS analysis results. Several proteins that were not detected in ∆idh1/2-pvtu strain was indicated by “--”.
Primer sequences for real-time RT-PCR.
|
|
|
|
|
|---|---|---|---|
| TDH3 | 5’ACGATGACAAGCACATCATC3’ | 5’ATGTGCTTTTGAGCAGTGTC3’ | 151 |
| ACO1 | 5’AGCAACTGGTCGTGGTAAGA3’ | 5’TGACATCCAATGGCCAGTTA3’ | 216 |
| TRX2 | 5’ATACGACAGTGCTTTAGCAT3’ | 5’TAGGCATGGAAGAAACTTCA3’ | 194 |
| ADH1 | 5’CACGAAGGTGCCGGTGTCGT3’ | 5’AGAACCGTCGTGGGTGTAAC3’ | 177 |
| PYK1 | 5’TGGACGACGGGATTCTCTCT3’ | 5’GACTCCGAATTGCAAGTCCT3’ | 176 |
| MLS1 | 5’CCAAAGATGGAGCACCACTT3’ | 5’AGTCCCAACGTCCGCAATTC3’ | 196 |
| SHM2 | 5’TGTTTACTCCGCTATCATGA3’ | 5’TTGGCCAATACTTGCAAGTT3’ | 198 |
| GPD1 | 5’AACATTGCCACCGAAGTCGC3’ | 5’CAACAACGTTCTTCAAAGCA3’ | 199 |
| SDH1 | 5’CTTTGCCCTCGATCTGTTGA3’ | 5’ATGCTCTACCATAGCCACCA3’ | 131 |
| ACT1 | 5’ AACTTTCAACGTTCCAGCCT3’ | 5’ CCACGTTCACTCAAGATCTT3’ | 216 |
Figure 1Real-time RT-PCR analysis of mRNA levels of selected differentially expressed proteins among wt-pvtu, ∆idh1/2-pvtu and ∆idh1/2-acl strains.
Three independent experiments were carried out. The mRNA levels in wt-pvtu strain were taken as controls (100%) and mRNA levels in ∆idh1/2-pvtu and ∆idh1/2-acl strains were being ratio to that in the wt-pvtu strain.
Figure 2Differential production levels of intracellular amino acids among wt-pvtu, ∆idh1/2-pvtu and ∆idh1/2-acl strains.
Three independent experiments were carried out. The amino acid levels in wt-pvtu strain were taken as controls and the amino acid levels in ∆idh1/2-pvtu and ∆idh1/2-acl strains were calculated accordingly.
Figure 3Differential production levels of intracellular metabolites among wt-pvtu, ∆idh1/2-pvtu and ∆idh1/2-acl strains.
Three independent experiments were carried out. The metabolites production levels in wt-pvtu strain were taken as controls and the metabolites production levels in ∆idh1/2-pvtu and ∆idh1/2-acl strains were calculated accordingly.
Figure 4Schematic diagram of metabolic pathway changes in S.
.
The engineered pathway in yeast with enhanced fatty acid synthesis was indicated by red dashed box. Both of the up-regulated and down regulated metabolic pathways in ∆idh1/2-acl strain were indicated by the different colored arrows. The proteins involved in other pathways that haven’t been detected from LC-MS/MS analysis were not shown in this diagram.